Form S-1MEF Arcus Biosciences, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
Arcus Biosciences (RCUS) IPO Opens 33% Higher
March 15, 2018 10:52 AM EDTToday's IPO for Arcus Biosciences (NYSE: RCUS) opened at $20 after pricing 8,000,000 shares of common stock at a price to the public of $15.00 per share for total gross proceeds of $120,000,000.
The Company has also granted the underwriters a 30-day option to purchase from the... More
